Stocks · Health care · Surgical & Medical Instruments & Apparatus

ICU MEDICAL INC/DE

ICUI Clue Score28
United States Fiscal year ends December CIK 0000883984
$160.32 +2.00% Close, 9 Oct 2026
Price $160.32 −28.69% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue379.4Operating income82.9Net income63.1EPS, diluted3.66Fiscal year 2017Revenue1,292.6 +240.7%Operating income−13.3Net income68.6 +8.8%EPS, diluted3.29 −10.1%Fiscal year 2018Revenue1,400.0 +8.3%Operating income29.8Net income28.8 −58.1%EPS, diluted1.33 −59.6%Fiscal year 2019Revenue1,266.2 −9.6%Operating income107.4Net income101.0 +250.9%EPS, diluted4.69 +252.6%Fiscal year 2020Revenue1,271.0 +0.4%Operating income98.2Net income86.9 −14.0%EPS, diluted4.02 −14.3%Fiscal year 2021Revenue1,316.3 +3.6%Operating income123.2Net income103.1 +18.7%EPS, diluted4.74 +17.9%Fiscal year 2022Revenue2,280.0 +73.2%Operating income−42.9Net income−74.3 −172.0%EPS, diluted−3.11 −165.6%Fiscal year 2023Revenue2,259.1 −0.9%Operating income22.8Net income−29.7EPS, diluted−1.23Fiscal year 2024Revenue2,382.0 +5.4%Operating income43.0Net income−117.7EPS, diluted−4.83Fiscal year 2025Revenue2,231.3 −6.3%Operating income42.8Net income0.7EPS, diluted0.03
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 379.4 1,292.6 1,400.0 1,266.2 1,271.0 1,316.3 2,280.0 2,259.1 2,382.0 2,231.3
Growth +240.7% +8.3% −9.6% +0.4% +3.6% +73.2% −0.9% +5.4% −6.3%
Operating income 82.9 −13.3 29.8 107.4 98.2 123.2 −42.9 22.8 43.0 42.8
Net income 63.1 68.6 28.8 101.0 86.9 103.1 −74.3 −29.7 −117.7 0.7
Growth +8.8% −58.1% +250.9% −14.0% +18.7% −172.0%
EPS, diluted 3.66 3.29 1.33 4.69 4.02 4.74 −3.11 −1.23 −4.83 0.03
Growth −10.1% −59.6% +252.6% −14.3% +17.9% −165.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin53.1%Operating margin21.9%Net margin16.6%Free cash flow margin17.6%Fiscal year 2017Gross margin33.0%Operating margin−1.0%Net margin5.3%Free cash flow margin6.2%Fiscal year 2018Gross margin40.7%Operating margin2.1%Net margin2.1%Free cash flow margin4.8%Fiscal year 2019Gross margin37.3%Operating margin8.5%Net margin8.0%Free cash flow margin0.4%Fiscal year 2020Gross margin36.3%Operating margin7.7%Net margin6.8%Free cash flow margin10.3%Fiscal year 2021Gross margin37.3%Operating margin9.4%Net margin7.8%Free cash flow margin15.1%Fiscal year 2022Gross margin30.6%Operating margin−1.9%Net margin−3.3%Free cash flow margin−6.7%Fiscal year 2023Gross margin32.8%Operating margin1.0%Net margin−1.3%Free cash flow margin3.6%Fiscal year 2024Gross margin34.6%Operating margin1.8%Net margin−4.9%Free cash flow margin5.2%Fiscal year 2025Gross margin36.8%Operating margin1.9%Net margin0.0%Free cash flow margin4.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 53.1% 33.0% 40.7% 37.3% 36.3% 37.3% 30.6% 32.8% 34.6% 36.8%
Operating margin 21.9% −1.0% 2.1% 8.5% 7.7% 9.4% −1.9% 1.0% 1.8% 1.9%
Net margin 16.6% 5.3% 2.1% 8.0% 6.8% 7.8% −3.3% −1.3% −4.9% 0.0%
Free cash flow margin 17.6% 6.2% 4.8% 0.4% 10.3% 15.1% −6.7% 3.6% 5.2% 4.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow89.9Capital expenditure−23.4Free cash flow66.6Buybacks−17.2Fiscal year 2017Operating cash flow154.4Capital expenditure−74.5Free cash flow79.9 +20.1%Buybacks−4.1Fiscal year 2018Operating cash flow160.2Capital expenditure−92.7Free cash flow67.5 −15.6%Buybacks−6.3Fiscal year 2019Operating cash flow101.9Capital expenditure−97.3Free cash flow4.6 −93.2%Buybacks−18.6Fiscal year 2020Operating cash flow222.8Capital expenditure−92.0Free cash flow130.7 +2,738.6%Buybacks−12.9Fiscal year 2021Operating cash flow267.5Capital expenditure−68.5Free cash flow199.0 +52.2%Buybacks−8.3Fiscal year 2022Operating cash flow−62.1Capital expenditure−90.3Free cash flow−152.4 −176.6%Buybacks−10.9Fiscal year 2023Operating cash flow166.2Capital expenditure−83.9Free cash flow82.3Buybacks−9.4Fiscal year 2024Operating cash flow204.0Capital expenditure−79.4Free cash flow124.7 +51.5%Buybacks−12.0Fiscal year 2025Operating cash flow179.8Capital expenditure−88.0Free cash flow91.8 −26.4%Buybacks−8.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 89.9 154.4 160.2 101.9 222.8 267.5 −62.1 166.2 204.0 179.8
Capital expenditure −23.4 −74.5 −92.7 −97.3 −92.0 −68.5 −90.3 −83.9 −79.4 −88.0
Free cash flow 66.6 79.9 67.5 4.6 130.7 199.0 −152.4 82.3 124.7 91.8
Growth +20.1% −15.6% −93.2% +2,738.6% +52.2% −176.6% +51.5% −26.4%
Buybacks −17.2 −4.1 −6.3 −18.6 −12.9 −8.3 −10.9 −9.4 −12.0 −8.8

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash445.1Total debt0.0Net cash (debt)445.1Shareholders’ equity660.2Debt to equity0.00Fiscal year 2017Cash290.1Shareholders’ equity1,198.3Fiscal year 2018Cash344.8Shareholders’ equity1,263.7Fiscal year 2019Cash268.7Total debt0.0Net cash (debt)268.7Shareholders’ equity1,377.2Debt to equity0.00Fiscal year 2020Cash396.1Shareholders’ equity1,502.3Fiscal year 2021Cash552.8Total debt0.0Net cash (debt)552.8Shareholders’ equity1,616.0Debt to equity0.00Fiscal year 2022Cash208.8Total debt1,653.4Net cash (debt)−1,444.6Shareholders’ equity2,089.9Debt to equity0.79Fiscal year 2023Cash254.2Total debt1,628.8Net cash (debt)−1,374.5Shareholders’ equity2,123.4Debt to equity0.77Fiscal year 2024Cash308.6Total debt1,582.9Net cash (debt)−1,274.3Shareholders’ equity1,965.2Debt to equity0.81Fiscal year 2025Cash308.0Total debt1,284.7Net cash (debt)−976.7Shareholders’ equity2,123.8Debt to equity0.60
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 445.1 290.1 344.8 268.7 396.1 552.8 208.8 254.2 308.6 308.0
Total debt 0.0 n/a n/a 0.0 n/a 0.0 1,653.4 1,628.8 1,582.9 1,284.7
Net cash (debt) 445.1 n/a n/a 268.7 n/a 552.8 −1,444.6 −1,374.5 −1,274.3 −976.7
Shareholders’ equity 660.2 1,198.3 1,263.7 1,377.2 1,502.3 1,616.0 2,089.9 2,123.4 1,965.2 2,123.8
Debt to equity 0.00 n/a n/a 0.00 n/a 0.00 0.79 0.77 0.81 0.60

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
379.4 1,292.6 1,400.0 1,266.2 1,271.0 1,316.3 2,280.0 2,259.1 2,382.0 2,231.3
Growth +240.7% +8.3% −9.6% +0.4% +3.6% +73.2% −0.9% +5.4% −6.3%
178.0 866.5 830.0 794.3 809.5 824.8 1,582.2 1,519.3 1,557.3 1,409.2
201.4 426.1 570.0 471.9 461.5 491.5 697.8 739.9 824.8 822.0
Growth +111.6% +33.8% −17.2% −2.2% +6.5% +42.0% +6.0% +11.5% −0.3%
13.0 51.3 52.9 48.6 42.9 47.5 93.0 85.3 88.6 87.5
89.4 302.2 320.0 277.0 284.0 302.6 608.3 606.7 638.8 625.2
82.9 −13.3 29.8 107.4 98.2 123.2 −42.9 22.8 43.0 42.8
Growth −116.0% +260.8% −8.6% +25.6% −134.8% +88.2% −0.3%
85.2 51.3 22.4 114.7 97.5 n/a n/a −78.3 −66.0 4.4
22.1 −17.4 −6.4 13.7 10.6 20.1 −40.1 −48.6 51.7 2.4
63.1 68.6 28.8 101.0 86.9 103.1 −74.3 −29.7 −117.7 0.7
Growth +8.8% −58.1% +250.9% −14.0% +18.7% −172.0%
Per share
3.90 3.50 1.41 4.90 4.16 4.86 −3.11 −1.23 −4.83 0.03
3.66 3.29 1.33 4.69 4.02 4.74 −3.11 −1.23 −4.83 0.03
Growth −10.1% −59.6% +252.6% −14.3% +17.9% −165.6%
16.2 19.6 20.4 20.6 20.9 21.2 23.9 24.1 24.4 24.6
17.3 20.9 21.6 21.5 21.6 21.8 23.9 24.1 24.4 24.9
Growth +20.9% +3.6% −0.3% +0.2% +0.9% +9.6% +0.9% +1.2% +2.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 11.9% a year over five years, and earnings per share fell 62.5% a year.
  • The diluted share count rose 15.3% in five years, which is dilution.
  • Operating margin is down 5.8 points on five years ago, at 1.9%.
  • A net loss in 3 of 10 years on file.